Literature DB >> 18574211

Polycystic ovary syndrome in adolescence.

Susan K Blank1, Kristin D Helm, Christopher R McCartney, John C Marshall.   

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive-aged women and is characterized by hyperandrogenemia, menstrual dysfunction, and polycystic ovarian morphology. The hormonal abnormalities inherent in PCOS often begin in adolescence and include hyperinsulinemia and rapid luteinizing hormone (LH) pulse frequency, both of which mediate ovarian and adrenal overproduction of androgens. Although differences exist regarding the diagnostic criteria for PCOS, we believe that hyperandrogenemia is the final common pathway for the development of adolescent PCOS, and we propose a hypothesis to illustrate such. Recognizing and reducing androgen levels in adolescence is critical given their association with the metabolic syndrome (MBS), diabetes, and infertility in adulthood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18574211     DOI: 10.1196/annals.1429.005

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  22 in total

1.  Interventional studies for polycystic ovarian syndrome in children and adolescents.

Authors:  Patricia Myriam Vuguin
Journal:  Ped Health       Date:  2010-02

Review 2.  Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies.

Authors:  Manmohan K Kamboj; Andrea E Bonny
Journal:  Transl Pediatr       Date:  2017-10

3.  Morning Circadian Misalignment Is Associated With Insulin Resistance in Girls With Obesity and Polycystic Ovarian Syndrome.

Authors:  Stacey L Simon; Laura McWhirter; Cecilia Diniz Behn; Kate M Bubar; Jill L Kaar; Laura Pyle; Haseeb Rahat; Yesenia Garcia-Reyes; Anne-Marie Carreau; Kenneth P Wright; Kristen J Nadeau; Melanie Cree-Green
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

4.  Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.

Authors:  Sonali S Patel; Uyen Truong; Martina King; Annie Ferland; Kerrie L Moreau; Jennifer Dorosz; John E Hokanson; Hong Wang; Gregory L Kinney; David M Maahs; Robert H Eckel; Kristen J Nadeau; Melanie Cree-Green
Journal:  Vasc Med       Date:  2017-01-17       Impact factor: 3.239

Review 5.  Dermatologic manifestations of endocrine disorders.

Authors:  Michael Lause; Alisha Kamboj; Esteban Fernandez Faith
Journal:  Transl Pediatr       Date:  2017-10

6.  Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome.

Authors:  W K McGee; C V Bishop; A Bahar; C R Pohl; R J Chang; J C Marshall; F K Pau; R L Stouffer; J L Cameron
Journal:  Hum Reprod       Date:  2011-11-23       Impact factor: 6.918

7.  The diagnosis of polycystic ovary syndrome in adolescents.

Authors:  Andrea Hsu Roe; Anuja Dokras
Journal:  Rev Obstet Gynecol       Date:  2011

Review 8.  Ultrasonographic and multimodal imaging of pediatric genital female diseases.

Authors:  Maria Grazia Caprio; Marco Di Serafino; Alessia De Feo; Elvira Guerriero; Teresa Perillo; Luigi Barbuto; Norberto Vezzali; Eugenio Rossi; Federica Ferro; Gianfranco Vallone; Cinzia Orazi
Journal:  J Ultrasound       Date:  2019-02-19

9.  Western-style diet, with and without chronic androgen treatment, alters the number, structure, and function of small antral follicles in ovaries of young adult monkeys.

Authors:  Cecily V Bishop; Fuhua Xu; Jing Xu; Alison Y Ting; Etienne Galbreath; Whitney K McGee; Mary B Zelinski; Jon D Hennebold; Judy L Cameron; Richard L Stouffer
Journal:  Fertil Steril       Date:  2015-12-21       Impact factor: 7.329

10.  Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.

Authors:  Corrine K Welt; Enrico Carmina
Journal:  J Clin Endocrinol Metab       Date:  2013-09-24       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.